Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zoetis

164.33
-4.4900-2.66%
Post-market: 164.330.00000.00%18:52 EDT
Volume:2.97M
Turnover:490.11M
Market Cap:73.16B
PE:29.50
High:167.38
Open:164.96
Low:163.51
Close:168.82
Loading ...

What Makes Zoetis (ZTS) a Compelling Opportunity?

Insider Monkey
·
28 Feb

Here's why the U.S. is not working to vaccinate birds against avian flu

Dow Jones
·
28 Feb

BNP Paribas Exane Adjusts Price Target on Zoetis to $219 From $232, Keeps Outperform Rating

MT Newswires Live
·
27 Feb

Zoetis Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
27 Feb

Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Feb

Zoetis Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
22 Feb

EXPLAINER-How bird flu has sent US eggs prices skyrocketing

Reuters
·
22 Feb

2 Healthcare Stocks with Big Upside and 1 to Skip

StockStory
·
21 Feb

Zoetis Inc. (NYSE:ZTS) Delivered A Better ROE Than Its Industry

Simply Wall St.
·
21 Feb

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

Dow Jones
·
20 Feb

Jefferies Cuts Zoetis' Price Target to $190 From $200

MT Newswires Live
·
20 Feb

Turkey to export 15,000 tonnes of eggs to US amid bird flu disruptions

Reuters
·
19 Feb

Turkey to Export 15,000 Tonnes of Eggs to U.S. Amid U.S. Bird Flu Disruptions, Turkish Sector Head Says

THOMSON REUTERS
·
19 Feb

Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens

Benzinga
·
18 Feb

French bird flu vaccine campaign helps poultry output recover, producers say

Reuters
·
18 Feb

BTIG Adjusts Price Target on Zoetis to $200 From $225, Keeps Buy Rating

MT Newswires Live
·
18 Feb

Zoetis Inc : Btig Cuts Target Price to $200 From $225

THOMSON REUTERS
·
18 Feb

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Agios Pharma (AGIO) and Dexcom (DXCM)

TIPRANKS
·
17 Feb

Why Zoetis Inc. (ZTS) Is Among the Best Drug Stocks to Buy Now

Insider Monkey
·
17 Feb

2.9% earnings growth over 3 years has not materialized into gains for Zoetis (NYSE:ZTS) shareholders over that period

Simply Wall St.
·
16 Feb